Corient Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Corient Capital Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$216K	Hold
2022 Q2	$216K	Sell
2022 Q1	$327K	Buy
2021 Q4	$331K	Buy
2021 Q3	$327K	Buy
2021 Q2	$247K	Buy
2021 Q1	$200K	Buy